These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2788748)

  • 1. Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor.
    McGillis JP; Park A; Rubin-Fletter P; Turck C; Dallman MF; Payan DG
    J Neurosci Res; 1989 Jul; 23(3):346-52. PubMed ID: 2788748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the relationship between cadmium immunotoxicity and corticotropin-releasing factor].
    Zhang X; Li D; Dong S; Zhang J
    Wei Sheng Yan Jiu; 2000 Jul; 29(4):193-6. PubMed ID: 12520913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead stimulates lymphocyte proliferation through enhanced T cell-B cell interaction.
    Razani-Boroujerdi S; Edwards B; Sopori ML
    J Pharmacol Exp Ther; 1999 Feb; 288(2):714-9. PubMed ID: 9918580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
    Curtis AL; Grigoriadis DE; Page ME; Rivier J; Valentino RJ
    J Pharmacol Exp Ther; 1994 Jan; 268(1):359-65. PubMed ID: 8301577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody (AE3.d3) with mitogenic properties for murine B cells.
    Allouche M; Basch RS; Berman JW
    J Immunol; 1984 Nov; 133(5):2301-7. PubMed ID: 6384364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
    Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G
    J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of corticotropin-releasing factor in primary and secondary lymphoid organs of the rat.
    Brouxhon SM; Prasad AV; Joseph SA; Felten DL; Bellinger DL
    Brain Behav Immun; 1998 Jun; 12(2):107-22. PubMed ID: 9646936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the migration of B and T lymphocytes: organ-selective localization in vivo and the role of lymphocyte-endothelial cell recognition.
    Stevens SK; Weissman IL; Butcher EC
    J Immunol; 1982 Feb; 128(2):844-51. PubMed ID: 6976385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of extensive lymphocyte death in sheep Peyer's patches. II. The number and fate of newly-formed lymphocytes that emigrate from Peyer's patches.
    Pabst R; Reynolds JD
    J Immunol; 1986 Mar; 136(6):2011-7. PubMed ID: 3950408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of corticotropin releasing factor on the production of adrenocorticotropic hormone by leukocyte populations.
    Hendricks GL; Mashaly MM
    Br Poult Sci; 1998 Mar; 39(1):123-7. PubMed ID: 9568309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
    Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
    J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lymphocyte blast transformation by purified fibronectin in vitro.
    Lause DB; Beezhold DH; Doran JE
    J Immunol; 1984 Mar; 132(3):1294-9. PubMed ID: 6319492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of corticotropin-releasing factor receptor-mediated adenylate cyclase activity in the rat central nervous system.
    Battaglia G; Webster EL; De Souza EB
    Synapse; 1987; 1(6):572-81. PubMed ID: 2843998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated intracerebral teneurin C-terminal associated peptide (TCAP)-1 injections produce enduring changes in behavioral responses to corticotropin-releasing factor (CRF) in rat models of anxiety.
    Tan LA; Xu K; Vaccarino FJ; Lovejoy DA; Rotzinger S
    Behav Brain Res; 2008 Mar; 188(1):195-200. PubMed ID: 18082275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective actions of corticotropin-releasing factor on thermal injury to rat pawskin.
    Wei ET; Serda S; Tian JQ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1082-5. PubMed ID: 3264573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.
    Riviere PJ; Pascaud X; Chevalier E; Junien JL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):846-50. PubMed ID: 7932195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of immunoreactive corticotropin releasing factor and adrenocorticotropic hormone by T- and B-lymphocytes in response to cellular stress factors.
    Kravchenco IV; Furalev VA
    Biochem Biophys Res Commun; 1994 Oct; 204(2):828-34. PubMed ID: 7980549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of rat B lymphocytes. I. Characterization of anti-immunoglobulin responses and isotype density of rat B cells.
    Rosenberg JS; Feldman JD
    J Immunol; 1982 Feb; 128(2):651-5. PubMed ID: 6798118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.